• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌感染

Helicobacter pylori infection.

作者信息

Axon A T

机构信息

Gastroenterology Unit, General Infirmary, Leeds, UK.

出版信息

J Antimicrob Chemother. 1993 Jul;32 Suppl A:61-8. doi: 10.1093/jac/32.suppl_a.61.

DOI:10.1093/jac/32.suppl_a.61
PMID:8407699
Abstract

The discovery of Helicobacter pylori is arguably the most significant advance made in gastroduodenal pathology this century. It is the most important cause of chronic gastritis, and almost certainly the major aetiological factor responsible for duodenal ulcer and probably for gastric ulcer as well. Evidence is accumulating which suggests that it may play an important role in the pathogenesis of gastric cancer. H. pylori is thought to be transmitted by the faecal-oral route or possibly oral-oral route, with iatrogenic transmission also reported. The prevalence of H. pylori infection increases with age, is commonest in developing countries, in certain ethnic minorities and those in lower socio-economic and educational groups. The organism can be eradicated using combinations of antibiotics; when treatment is successful inflammatory changes resolve, duodenal ulcers heal and do not subsequently recur.

摘要

幽门螺杆菌的发现可以说是本世纪胃肠病理学领域取得的最重大进展。它是慢性胃炎最重要的病因,几乎肯定是十二指肠溃疡的主要致病因素,也可能是胃溃疡的主要致病因素。越来越多的证据表明,它可能在胃癌的发病机制中发挥重要作用。幽门螺杆菌被认为通过粪-口途径传播,也可能通过口-口途径传播,也有医源性传播的报道。幽门螺杆菌感染率随年龄增长而增加,在发展中国家、某些少数民族以及社会经济和教育水平较低的人群中最为常见。使用抗生素联合治疗可以根除这种细菌;治疗成功后,炎症变化会消退,十二指肠溃疡会愈合且随后不会复发。

相似文献

1
Helicobacter pylori infection.幽门螺杆菌感染
J Antimicrob Chemother. 1993 Jul;32 Suppl A:61-8. doi: 10.1093/jac/32.suppl_a.61.
2
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.甲硝唑+四环素+枸橼酸铋钾与奥美拉唑+阿莫西林+枸橼酸铋钾治疗幽门螺杆菌相关性胃炎和消化性溃疡疾病的药理作用比较
Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S103-7.
3
[Helicobacter pylori and gastroduodenal pathology. Second part: Clinical aspects and therapy].[幽门螺杆菌与胃十二指肠病理学。第二部分:临床方面与治疗]
Gastroenterol Clin Biol. 1991;15(5):412-20.
4
Helicobacter pylori and gastric or duodenal ulcer.幽门螺杆菌与胃或十二指肠溃疡。
Prescrire Int. 2016 Jan;25(167):18-23.
5
The role of Helicobacter pylori in peptic ulcer disease.幽门螺杆菌在消化性溃疡疾病中的作用。
Gastroenterol Jpn. 1993 May;28 Suppl 5:163-7. doi: 10.1007/BF02989228.
6
Eradication of Helicobacter pylori.幽门螺杆菌的根除
Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S113-9.
7
Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.出血性溃疡的抗幽门螺杆菌治疗:比较2天与7天铋剂四联疗法的随机对照试验
Am J Gastroenterol. 1997 Mar;92(3):438-41.
8
[Treatment of Helicobacter pylori infections].[幽门螺杆菌感染的治疗]
Ned Tijdschr Geneeskd. 1999 Feb 20;143(8):395-400.
9
History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer.幽门螺杆菌、十二指肠溃疡、胃溃疡及胃癌病史。
World J Gastroenterol. 2014 May 14;20(18):5191-204. doi: 10.3748/wjg.v20.i18.5191.
10
[Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole].
Tidsskr Nor Laegeforen. 1992 Oct 20;112(25):3197-9.

引用本文的文献

1
Comparison of Secular Trends in Peptic Ulcer Diseases Mortality in China, Brazil and India during 1990-2019: An Age-Period-Cohort Analysis.1990 - 2019年中国、巴西和印度消化性溃疡疾病死亡率的长期趋势比较:年龄-时期-队列分析
Healthcare (Basel). 2023 Apr 11;11(8):1085. doi: 10.3390/healthcare11081085.
2
Primer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship.基于抗菌药物管理制定幽门螺杆菌治疗指南的基础
Clin Gastroenterol Hepatol. 2022 May;20(5):973-983.e1. doi: 10.1016/j.cgh.2021.03.026. Epub 2021 Mar 26.
3
Helicobacter pylori eradication: gastric cancer prevention.
幽门螺杆菌根除:预防胃癌
BMJ Clin Evid. 2015 Dec 1;2015:0406.
4
Helicobacter pylori infection.幽门螺杆菌感染
BMJ Clin Evid. 2009 Oct 1;2009:0406.
5
Helicobacter pylori and antibiotic resistance.幽门螺杆菌与抗生素耐药性。
Gut. 2007 Nov;56(11):1502. doi: 10.1136/gut.2007.132514.
6
Helicobacter pylori in gastroduodenal diseases.胃十二指肠疾病中的幽门螺杆菌
J Natl Med Assoc. 2007 Jan;99(1):31-4.
7
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin.使用奥美拉唑联合克拉霉素或阿莫西林进行幽门螺杆菌根除治疗的决策分析。
Pharmacoeconomics. 1996 Jul;10(1):79-92. doi: 10.2165/00019053-199610010-00008.
8
Recognition of glycoconjugates by Helicobacter pylori: an apparently high-affinity binding of human polyglycosylceramides, a second sialic acid-based specificity.幽门螺杆菌对糖缀合物的识别:人多聚糖神经酰胺的一种明显的高亲和力结合,一种基于唾液酸的第二种特异性。
Glycoconj J. 1996 Jun;13(3):453-60. doi: 10.1007/BF00731478.
9
Transportation of Helicobacter pylori cultures by optimal systems.通过优化系统运输幽门螺杆菌培养物。
J Clin Microbiol. 1994 Dec;32(12):3075-7. doi: 10.1128/jcm.32.12.3075-3077.1994.
10
Factors affecting growth and susceptibility testing of Helicobacter pylori in liquid media.影响幽门螺杆菌在液体培养基中生长及药敏试验的因素。
J Clin Microbiol. 1995 Apr;33(4):1028-30. doi: 10.1128/jcm.33.4.1028-1030.1995.